ACET
Price
$0.76
Change
-$0.02 (-2.56%)
Updated
Jul 25 closing price
Capitalization
64.16M
11 days until earnings call
NXTC
Price
$6.17
Change
+$0.91 (+17.30%)
Updated
Jul 25 closing price
Capitalization
14.42M
5 days until earnings call
Interact to see
Advertisement

ACET vs NXTC

Header iconACET vs NXTC Comparison
Open Charts ACET vs NXTCBanner chart's image
Adicet Bio
Price$0.76
Change-$0.02 (-2.56%)
Volume$123.2K
Capitalization64.16M
NextCure
Price$6.17
Change+$0.91 (+17.30%)
Volume$3.62M
Capitalization14.42M
ACET vs NXTC Comparison Chart in %
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. NXTC commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a StrongBuy and NXTC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (ACET: $0.77 vs. NXTC: $6.17)
Brand notoriety: ACET and NXTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACET: 30% vs. NXTC: 2418%
Market capitalization -- ACET: $64.16M vs. NXTC: $14.42M
ACET [@Biotechnology] is valued at $64.16M. NXTC’s [@Biotechnology] market capitalization is $14.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 2 FA rating(s) are green whileNXTC’s FA Score has 1 green FA rating(s).

  • ACET’s FA Score: 2 green, 3 red.
  • NXTC’s FA Score: 1 green, 4 red.
According to our system of comparison, ACET is a better buy in the long-term than NXTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 5 TA indicator(s) are bullish while NXTC’s TA Score has 5 bullish TA indicator(s).

  • ACET’s TA Score: 5 bullish, 5 bearish.
  • NXTC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NXTC is a better buy in the short-term than ACET.

Price Growth

ACET (@Biotechnology) experienced а +1.58% price change this week, while NXTC (@Biotechnology) price change was +23.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ACET is expected to report earnings on Nov 05, 2025.

NXTC is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACET($64.2M) has a higher market cap than NXTC($14.4M). ACET YTD gains are higher at: -19.802 vs. NXTC (-33.312). NXTC has higher annual earnings (EBITDA): -50.34M vs. ACET (-110.82M). ACET has more cash in the bank: 150M vs. NXTC (15.4M). NXTC has less debt than ACET: NXTC (4.91M) vs ACET (16.2M). ACET (0) and NXTC (0) have equivalent revenues.
ACETNXTCACET / NXTC
Capitalization64.2M14.4M446%
EBITDA-110.82M-50.34M220%
Gain YTD-19.802-33.31259%
P/E RatioN/AN/A-
Revenue00-
Total Cash150M15.4M974%
Total Debt16.2M4.91M330%
FUNDAMENTALS RATINGS
ACET vs NXTC: Fundamental Ratings
ACET
NXTC
OUTLOOK RATING
1..100
1896
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
13
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
5089
P/E GROWTH RATING
1..100
19100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NXTC's Valuation (13) in the Biotechnology industry is in the same range as ACET (30) in the Medical Distributors industry. This means that NXTC’s stock grew similarly to ACET’s over the last 12 months.

NXTC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ACET (100) in the Medical Distributors industry. This means that NXTC’s stock grew similarly to ACET’s over the last 12 months.

ACET's SMR Rating (97) in the Medical Distributors industry is in the same range as NXTC (100) in the Biotechnology industry. This means that ACET’s stock grew similarly to NXTC’s over the last 12 months.

ACET's Price Growth Rating (50) in the Medical Distributors industry is somewhat better than the same rating for NXTC (89) in the Biotechnology industry. This means that ACET’s stock grew somewhat faster than NXTC’s over the last 12 months.

ACET's P/E Growth Rating (19) in the Medical Distributors industry is significantly better than the same rating for NXTC (100) in the Biotechnology industry. This means that ACET’s stock grew significantly faster than NXTC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETNXTC
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UAA7.360.19
+2.65%
Under Armour
CTNM5.770.07
+1.23%
Contineum Therapeutics
ARE82.190.14
+0.17%
Alexandria Real Estate Equities
AMAL30.06-0.45
-1.47%
Amalgamated Financial Corp
CYN8.89-0.49
-5.22%
Cyngn Inc.

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with SYRE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
-0.54%
SYRE - ACET
42%
Loosely correlated
+1.08%
OGI - ACET
41%
Loosely correlated
+1.32%
INBX - ACET
40%
Loosely correlated
+0.04%
RGNX - ACET
40%
Loosely correlated
-1.86%
ARWR - ACET
40%
Loosely correlated
-3.20%
More